Compare BIO & TRNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BIO | TRNO |
|---|---|---|
| Founded | 1952 | 2009 |
| Country | United States | United States |
| Employees | 7450 | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Real Estate |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 6.8B |
| IPO Year | N/A | 2009 |
| Metric | BIO | TRNO |
|---|---|---|
| Price | $277.40 | $65.12 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 12 |
| Target Price | ★ $339.75 | $67.83 |
| AVG Volume (30 Days) | 282.4K | ★ 502.8K |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 3.19% |
| EPS Growth | N/A | ★ 103.65 |
| EPS | N/A | ★ 3.91 |
| Revenue | N/A | ★ $476,383,000.00 |
| Revenue This Year | $2.59 | $8.79 |
| Revenue Next Year | $3.21 | $9.29 |
| P/E Ratio | ★ $9.72 | $16.72 |
| Revenue Growth | N/A | ★ 24.51 |
| 52 Week Low | $211.43 | $53.00 |
| 52 Week High | $343.12 | $66.74 |
| Indicator | BIO | TRNO |
|---|---|---|
| Relative Strength Index (RSI) | 52.60 | 64.50 |
| Support Level | $256.85 | $59.23 |
| Resistance Level | $289.61 | $66.68 |
| Average True Range (ATR) | 7.87 | 1.26 |
| MACD | 1.42 | 0.51 |
| Stochastic Oscillator | 61.26 | 84.84 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Terreno Realty Corp is a real estate investment trust engaged in acquiring, owning, and operating industrial real estate in six coastal U.S. markets: Los Angeles, Northern New Jersey/New York City, San Francisco Bay Area, Seattle, Miami, and Washington, D.C. The company invests in several types of industrial real estate, including warehouse/distribution, flex (including light industrial and research and development), transshipment, and improved land.